Article
Evolution of hepatitis C virus quasispecies during ribavirin and interferon-alpha-2b combination therapy and interferon-alpha-2b monotherapy.
Intervirology - 1 Jan 2006
Arataki Keiko, Kumada Hiromitsu, Toyota Kiyomi, Ohishi Waka, Takahashi Shoichi, Tazuma Susumu, Chayama Kazuaki
Abstract excerpt
OBJECTIVE: Ribavirin and interferon combination therapy is more effective than interferon monotherapy in patients with chronic hepatitis C virus (HCV) infection. To test the hypothesis that ribavirin induces nucleotide substitutions in the viral genome and reduces viral load by forcing it into error catastrophe in the combination therapy, we investigated the molecular evolution of HCV quasispecies in 3 patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
